Antimicrobial Resistance (AMR)

Dr Sarkar is a senior research fellow at the Murdoch Children's Research Institute in Melbourne, Australia. She is actively engaged in collaborating with academic and industry stakeholders and leads multiple projects for the development of novel therapeutics/vaccines to tackle antimicrobial resistance.

Dr Linny Kimly Phuong is a paediatric infectious diseases physician and researcher. She holds appointments at the Royal Children’s Hospital, Cabrini Health and the Murdoch Children’s Research Institute. Linny’s areas of research include paediatric infections, Kawasaki disease and vaccine safety.

Biology of Spiders is my interest for research. Thai spiders are my focus group.

I am a microbiologist currently working as a lecturer in the Medical Microbiology Department, Faculty of Applied Science, Hajjah University, Yemen. I am interested in research areas related to the prevalence of infectious diseases caused by bacteria, viruses, fungi, and parasites in different areas in Yemen.

A/Prof Matthew Tan is a Food Security Specialist and an Aquaculture veteran with more than 20 years’ experience in the Agritech Industry. He is currently driving several sustainability projects in the area of Carbon Neutral Engineering and specializes in Aquaculture & Agriculture carbon credit & sequestration with regards to regenerative & restorative activities in the areas of biodiversity, CSR aquaculture and use of climate smart technologies with the aim to develop true impact projects to reduce carbon emissions, plastic waste, protect biodiversity, and drive investment into local communities as he assist companies with their Carbon Transition Strategy and Planning.

Dr Ashfaq Ahmad Shah 'اشفاک ' born on 6 June 1992, from south Kashmir, Doderkoot ددیرکوٹ Kulgam, Jammu and Kashmir, India is the infection immunity doctoral researcher at the Graphic Era (Deemed to be University), Dehradun, UK, India. Dr Shah is pursuing novel dimensions of infection immunity pertaining to the correlation and impact of phyto-immune components termed phytoalexins and phytoanticipins on the benign immune system of human beings. This parameter of immunology is termed phytoalexin-immunomodulation scrutiny. His area of interest lies in Preclinical and clinical studies, i.e. vaccine adjuvant development, development of anti-inflammatory and antimicrobial compounds, evaluation of antibiotic resistance, study of Immuno-modulatory activities, disease model studies, protease isolation against specific protein antigens, and the discipline of Kalology including tyrosinase inhibition, PPO inhibition, skin whitening agents, kerato-peeling etc. Dr Ashfaq is a Doctoral Researcher, Reviewer and Editorial member of several journals and books. He is having several publications in journals of national and international repute. So far he has published more than thirty scopus infection/immunology/pharmacology scientific papers, including Fifteen international book chapters and two international books. Mr Shah received the Young scientist award in August 2023 for his groundbreaking academic performance in the field of infection immunity. Mr Shah has also been an editor of Wikipedia pages in medical science since 2015 with more than 1000 edits in medical topics available to medical literature worldwide.

Dr. Hira Khalid is serving as Associate Professor at Forman Christian College University, Lahore, Pakistan. She is also a US Fulbright Fellow and a member of several prestigious scientific organizations, including the American Chemical Society (ACS), the Royal Society of Chemistry (RSC), the International Union of Pure and Applied Chemistry (IUPAC), the Organization for Women in Science for the Developing World (OWSD), and the Chemical Society of Pakistan (CSP).

Dr. Crumlish has researched aquatic microbial diseases, specifically ones that have economic impact in global aquaculture, and potential solutions to such infectious diseases. Her current project seeks to develop vaccines against antimicrobial resistance in aquaculture.

Dr. Tay has researched antibodies and diseases like malaria and SARS-CoV-2 at A*STAR. His focus is on discovering methods for developing antibodies that can be used in therapies against multidrug-resistant pathogens.

Nguyen Huu Nghia is the Director of the Center for Environment and Disease Monitoring in Aquaculture (CEDMA) at the Research Institute for Aquaculture No.1 (RIA1) under Vietnam’s Ministry of Agriculture and Rural Development. He has co-managed various research efforts in Vietnam aquaculture as well as published recent research into the use of nanobubbles.

Dr. Van was previously the Director of the Research Institute for Aquaculture No.1 (RIA1) under Vietnam’s Ministry of Agriculture and Rural Development. She has extensive expertise in aquatic animal health and aquaculture safety management.

Dr. An is an associate professor at the School of Energy and Environment, City University of Hong Kong (CityU), where she also heads the Water and Membrane Technologies Laboratory.

Professor St-Hilaire is associate head and professor at the Department of Infectious Diseases and Public Health, City University of Hong Kong (CityU). She has extensively researched fish nutrition and diseases, including treatment efficacy, and has helped investigate fish disease outbreaks.

Dr. Ikhsan is an associate professor at the Department of Aquaculture, University Putra Malaysia. She specializes in the field of Aquatic Microbial Ecology particularly in the development of innovative and sustainable microbial management strategies through understanding of the host-microbe interaction for enhanced microbial stability.

Dr. Oehlers leads the Bacterial Pathogenesis Laboratory at A*STAR ID Labs, where he and his colleagues focus on identifying molecular bases of mycobacterial disease and, thus, deploy therapies that address antibiotic resistance in mycobacterial infections.

Dr. Yue Wang is senior principal investigator at the Antifungal Resistance Laboratory of A*STAR ID Labs, where his body of work focuses on virulence mechanisms of the fungal human pathogen Candida albicans.

Dr. Singhal serves as senior principal investigator at the Bacterial Immunopathology Lab at A*STAR ID Labs in Singapore. His work at A*STAR ID Labs revolves around three main pathogens: Mycobacterium tuberculosis, Gram-negative bacteria and Dengue virus.

Dr. Bifani is a principal investigator at A*STAR ID Labs at their Antimicrobial Resistance Lab. He has extensively researched antimicrobial resistance in tuberculosis and malaria. He is also an associate professor and research director at the Yong Yoo Lin School of Medicine, National University of Singapore.

Dr. Yan is an assistant professor at the Department of Biomedical Sciences, City University of Hong Kong (CityU). His current research focuses on developing genomic tools to dissect lncRNA function and mechanism in diseases and to identify genetic variations that contribute to disease pathogenesis.

Dr. Deng is a biomedical scientist with a special interest in bacterial virulence, including gene regulation, signaling pathways, and RNA epigenetics. He has worked on virulence regulation in pathogens to discover new therapies against bacterial infections.

Dr. Ozawa is a Specially Appointed Professor at the Department of Dermatology, Graduate School of Medicine, Osaka Metropolitan University (formerly Osaka City University). His specialized field is skin malignant tumor and surgery.

Dr. So Iwata is a Professor at the Graduate School of Medicine Kyoto University and the Group Director of the SACLA Science Research Group, RIKEN SPring-8 Center. He has investigated how specialized membrane channels remove antimicrobial drugs from inside bacterial cells.

Dr. Mitchell is a professor at the Department of Biological Sciences, Ulsan National Institute of Science and Technology (UNIST). His primary research interest is the study of bacterial strains that attack and prey on other bacteria, including antimicrobial-resistant pathogens.

Dr. Soojin Jang heads the Antibacterial Resistance Research Laboratory at Institut Pasteur Korea, where her team focuses on discovering new antibacterial agents for “superbugs” or bacteria resistant to most antibiotics.

Dr Kwa is currently a Pharmacy Clinician Scientist and Assistant Director, Pharmacy (Research), at the Singapore General Hospital. She specializes in critical care medicine, infectious diseases and antimicrobial resistance research.

Dr. Dong currently works at the Asian Institute of Technology. He does research in Aquaculture, Pathology, Infectious Diseases, and Aquatic Bioscience.

Suraj Bhattarai is a global health specialist and tropical medicine physician with research interests in infectious disease epidemiology and surveillance, health systems, and urban health. He is a co-founder and research fellow at the Global Institute for Interdisciplinary Studies, a Kathmandu-based academic institute that promotes and conducts interdisciplinary research. He is a member of Global Young Academy and an Alumni steering committee member of IAP-Young Physician Leaders Programme. He obtained medical training in Nepal and masters in Tropical Medicine & International Health from the LSHTM, UK.

Prof. Chen’s current research covers research on bacterial antimicrobial resistance, virulence and tolerance in the veterinary, food and medical microbiology fields